Trial Profile
A Phase 3, Multicenter, Observational Long-term Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2018
At a glance
- Drugs SM 04690 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Samumed
- 08 Nov 2016 New trial record